Dyadic International DYAI
NASDAQ DYAI
$0.46 +0.03 (+6.98%)
At close: Oct 2, 2026 · 4:00 PM EDT

Dyadic International (DYAI) Return on Sales [ROS] (2018 - 2026)

Updated

Dyadic International's Return on Sales [ROS] came in at -171.27% for Q1 2026, up 337.53 percentage points from -508.80% a year earlier and up 100.32 percentage points from the prior quarter.

Analysis

Dyadic International (DYAI) Return on Sales [ROS] (2018 - 2026) Analysis & Trends

Over the trailing twelve months to Mar 31, 2026, Dyadic International reported Return on Sales [ROS] of -186.28%, down 23.73 percentage points year-over-year; for FY2025, it came in at -232.75%, down 63.93 percentage points from FY2024.

  • Return on Sales [ROS] carries a five-year change of +393.10 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Sales [ROS] was -168.82% in FY2024 (+115.08 pp), -283.90% in FY2023 (+63.01 pp), -346.92% in FY2022 (+265.75 pp) and -612.67% in FY2021 (+13.19 pp).
  • The five-year range for quarterly Return on Sales [ROS] is -1345.65% (Q4 2021) to -10.35% (Q3 2024).
  • Year-over-year, Return on Sales [ROS] increased in five of the last eight quarters, with an average year-over-year change of +108.86 percentage points.
  • The fastest year-over-year change in Return on Sales [ROS] over five years came in Q4 2022 (a gain of 1044.52 percentage points), and the weakest in Q4 2021 (a drop of 689.76 percentage points).
  • Business Quant data shows DYAI's Return on Sales [ROS] at -271.59% (Q4 2025), -165.32% (Q3 2025) and -178.88% (Q2 2025) in the three quarters before Q1 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 Dyadic International 16.76 Mn 10.16 Mn - -171.27%
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -171.27%
Dec 31, 2025 -271.59%
Sep 30, 2025 -165.32%
Jun 30, 2025 -178.88%
Mar 31, 2025 -508.80%
Dec 31, 2024 -187.19%
Sep 30, 2024 -10.35%
Jun 30, 2024 -529.31%
Mar 31, 2024 -635.22%
Dec 31, 2023 -315.89%
Sep 30, 2023 -433.21%
Jun 30, 2023 -273.60%
Mar 31, 2023 -209.65%
Dec 31, 2022 -301.13%
Sep 30, 2022 -211.86%
Jun 30, 2022 -503.83%
Mar 31, 2022 -423.28%
Dec 31, 2021 -1,345.65%
Sep 30, 2021 -479.70%
Jun 30, 2021 -412.67%
API Access

Dyadic International Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=DYAI&period=max&api_key=YOUR_API_KEY